Delivery Order SPE2DB24D2205-SPE2DB25FEFGH
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLAREX 0.1% eye drops in 5 milliliter units, with a ceiling value of $7,127.40 and a final completion date of July 14, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product. The contract has a ceiling value of $7,347.51 and a period of performance that extends to July 16, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,838.84 firm fixed-price delivery order is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product used for ophthalmic treatment. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen is the prime contractor and there are no set-aside requirements indicated. The company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a $4,039.03 Firm Fixed Price Delivery Order for the supply of FLAREX 0.1% EYE DROPS 5ML. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- The Defense Logistics Agency awarded a $346,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562093840 FLAREX 0.1% eye drops. As the prime contractor, Amerisourcebergen will supply five milliliter bottles of the eye drops to meet requirements under the contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from September 8 to September 11, 2023. No major subcontractors or set aside designations were...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,356.51 firm fixed price delivery order is for the supply of FLAREX 0.1% eye drops, a specialty ophthalmic medication. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this order as well as other indefinite delivery contracts (IDCs) by the DLA and Department...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product, with a ceiling value of $4,365.64 and a performance period ending on June 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, does not have a set-aside designation for this award. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,821.70 delivery order covers the procurement of FLAREX 0.1% eye drops, a specialty ophthalmic medication, with a completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $1,646.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLAREX 0.1% eye drops, a pharmaceutical product, with a completion date of February 6, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,460.32 firm fixed-price delivery order is for FLAREX 0.1% eye drops, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFGHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,510.23 to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on July 23, 2025, with completion expected by July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly supplies medical commodities to support federal health systems through its extensive contract portfolio with DLA. This delivery order represents a typical transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the company's primary mechanism for supplying pharmaceutical products and medical supplies globally to military healthcare programs. The company's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its comprehensive portfolio spanning specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains, positions it as a critical vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/23/25 |